Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation

Published:2011-08 Issue:8 Volume:17 Page:1222-1230
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kim Sung-Doo,Lee Je-Hwan,Hur Eun-Hye,Lee Jung-Hee,Kim Dae-Young,Lim Sung-Nam,Choi Yunsuk,Lim Hyeong-Seok,Bae Kyun-Seop,Noh Gyu-Jeong,Yun Sung-Cheol,Han Sang Beom,Lee Kyoo-Hyung

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference53 articles.

1. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia;Brochstein;N Engl J Med,1987

2. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation—a report from the Societe Francaise de Greffe de Moelle;Michel;J Clin Oncol,1994

3. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide;Santos;N Engl J Med,1983

4. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen;Tutschka;Blood,1987

5. Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation;Copelan;Blood,1992

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2023-12-22

2. Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens;Best Practice & Research Clinical Haematology;2023-06

3. Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan;Annals of Hematology;2023-04-13

4. Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen;Bone Marrow Transplantation;2023-03-31

5. Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01